These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23105143)

  • 41. Direct targeting of genetically modified tumour cells to Fc gammaRI triggers potent tumour cytotoxicity.
    Bevaart L; Goldstein J; Vitale L; Russoniello C; Treml J; Zhang J; Graziano RF; Leusen JH; van de Winkel JG; Keler T
    Br J Haematol; 2006 Feb; 132(3):317-25. PubMed ID: 16409296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of native and heat-denatured Abrus agglutinin on tumor-associated macrophages in Dalton's lymphoma mice.
    Ghosh D; Maiti TK
    Immunobiology; 2007; 212(8):667-73. PubMed ID: 17869644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
    Zins K; Abraham D; Sioud M; Aharinejad S
    Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of colony-stimulating factor-1 in macrophage activation in tumor-bearing mice.
    Sakata T; Iwagami S; Tsuruta Y; Teraoka H; Suzuki S; Suzuki R
    J Immunol; 1992 Dec; 149(12):4002-8. PubMed ID: 1281198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.
    Wolfe AR; Trenton NJ; Debeb BG; Larson R; Ruffell B; Chu K; Hittelman W; Diehl M; Reuben JM; Ueno NT; Woodward WA
    Oncotarget; 2016 Dec; 7(50):82482-82492. PubMed ID: 27756885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitro.
    Kitoh Y; Saio M; Gotoh N; Umemura N; Nonaka K; Bai J; Vizkeleti L; Torocsik D; Balazs M; Adany R; Takami T
    Int J Oncol; 2011 May; 38(5):1409-19. PubMed ID: 21373754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells.
    Szabo KA; Singh G
    Breast Cancer Res; 2005; 7(5):R661-8. PubMed ID: 16168111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.
    Shimura S; Yang G; Ebara S; Wheeler TM; Frolov A; Thompson TC
    Cancer Res; 2000 Oct; 60(20):5857-61. PubMed ID: 11059783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrophages are critical effectors of antibody therapies for cancer.
    Weiskopf K; Weissman IL
    MAbs; 2015; 7(2):303-10. PubMed ID: 25667985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Muramyl dipeptide and mononuclear cell supernatant induce Langhans-type cells from human monocytes.
    Mizuno K; Okamoto H; Horio T
    J Leukoc Biol; 2001 Sep; 70(3):386-94. PubMed ID: 11527988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
    Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
    Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion.
    Li K; Wei L; Huang Y; Wu Y; Su M; Pang X; Wang N; Ji F; Zhong C; Chen T
    Int J Oncol; 2016 Jun; 48(6):2479-87. PubMed ID: 27082857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor-associated macrophages secrete CCL2 and induce the invasive phenotype of human breast epithelial cells through upregulation of ERO1-α and MMP-9.
    Lee S; Lee E; Ko E; Ham M; Lee HM; Kim ES; Koh M; Lim HK; Jung J; Park SY; Moon A
    Cancer Lett; 2018 Nov; 437():25-34. PubMed ID: 30165193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration.
    Zhang Y; Sime W; Juhas M; Sjölander A
    Eur J Cancer; 2013 Oct; 49(15):3320-34. PubMed ID: 23810249
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
    Qiu SQ; Waaijer SJH; Zwager MC; de Vries EGE; van der Vegt B; Schröder CP
    Cancer Treat Rev; 2018 Nov; 70():178-189. PubMed ID: 30227299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of tumor-associated macrophage in progression of human glioma.
    Ding P; Wang W; Wang J; Yang Z; Xue L
    Cell Biochem Biophys; 2014 Dec; 70(3):1625-31. PubMed ID: 25182001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: a quid pro quo in pancreatic cancer.
    Partecke LI; Günther C; Hagemann S; Jacobi C; Merkel M; Sendler M; van Rooijen N; Käding A; Nguyen Trung D; Lorenz E; Diedrich S; Weiss FU; Heidecke CD; von Bernstorff W
    Pancreatology; 2013; 13(5):508-16. PubMed ID: 24075516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation.
    Yin Y; Huang X; Lynn KD; Thorpe PE
    Cancer Immunol Res; 2013 Oct; 1(4):256-68. PubMed ID: 24777853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.
    Nie Y; Huang H; Guo M; Chen J; Wu W; Li W; Xu X; Lin X; Fu W; Yao Y; Zheng F; Luo ML; Saw PE; Yao H; Song E; Hu H
    Clin Cancer Res; 2019 Jul; 25(13):3873-3886. PubMed ID: 30890553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.